Tissue Engineering & 3D Bioprinting represents a revolutionary convergence of biomaterials, cellular biology, and digital fabrication technologies aimed at constructing functional tissues for therapeutic and research applications. Using bioinks composed of living cells and supportive matrices, scientists are now printing complex, multi-layered structures that mimic natural tissue architecture. This technique enables patient-specific constructs for skin, bone, cartilage, and even organ precursors. Tissue Engineering & 3D Bioprinting also supports advancements in disease modeling and drug screening by producing physiologically relevant tissue analogs. Innovations in scaffold design, vascularization, and bioprinter resolution continue to overcome previous limitations, moving the field closer to fully implantable and vascularized organs. Its implications span regenerative medicine, personalized implants, and fundamental biological research.
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States
Title : Advancement in dual lateral flow immunoassay design for sensitive, rapid detection of rotavirus and adenovirus in stool samples
Ayan Ahmed Isse, Genexus Biotech Company, Somalia
Title :
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Diversity analyses of microbial communities in Armanis gold-polymetallic mine and acid mine drainage: Bioremediation
Anna Khachatryan, SPC Armbiotechnology of NAS of Armenia, Armenia